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Highlights 
 Fetal fraction is a quality control parameter in NIPS 
 There are several methods for determining fetal fraction, including snpFF 
 snpFF is based on targeted sequencing of highly polymorphic SNPs 
 Individual SNP-level variability of fetal fraction is rather high 
 Uncertainty of snpFF increases with fetal fraction 
 snpFF cannot reliably measure fetal fraction below 2.5%  
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Fetal fraction and the chromosome representation are the two key quantities used in Non-
Invasive Prenatal Screening (NIPS) to determine the aneuploidy status of a fetus. Several 
methods for fetal fraction determination have been proposed in the literature, including a class 
of the methods, denoted snpFF, based on high-coverage targeted sequencing of highly 
polymorphic Single Nucleotide Polymorphisms (SNPs). The variant of snpFF, investigated here, 
has similar properties as the other variants of snpFF. We point out that the variability of the 
individual informative SNPs-based estimates of fetal fraction increases with the increase of fetal 
fraction. At 4% fetal fraction the Inter-Quartile Range (IQR) of the individual estimates of fetal 
fraction is around 3% and it increases to 6% at 15% fetal fraction. snpFF cannot detect fetal 
fraction below 2.5% because the number of informative SNPs becomes too small, even zero. 
 
Abbreviations:  NIPS, Non-Invasive Prenatal Screening; cfDNA, cell free DNA; WGS, Whole 
Genome Sequencing; SNP, Single Nucleotide Polymorphism; BAF, B Allele Frequency; QC, 
Quality Control; IQR, Inter-Quartile Range 
 
Keywords Fetal fraction, Single Nucleotide Polymorphism, NIPS  
 
1. Introduction 
The discovery of cell-free fetal DNA (cfDNA) in the plasma of pregnant women (Lo et al., 1997) 
has allowed the development of a wide range of Non-Invasive Prenatal Screening (NIPS) 
applications. Either the shallow-depth Whole Genome Sequencing (WGS)-based read-counting 
approach to NIPS or the targeted sequencing-based Single Nucleotide Polymorphism (SNP) 
approach to NIPS are used to detect aneuploidies, chromosomal microdeletions, 
microduplications and monogenic diseases.  
In NIPS, fetal fraction and the chromosome representation are the two basic characteristics of a 
sample. They are used to determine the aneuploidy status of a fetus. Moreover, fetal fraction is 
used for the Quality Control (QC). If fetal fraction of a sample is below the Limit of Detection 
(LoD) of NIPS the sample is reported as ‘no call’ and recommended for a redraw. The LoD of 
NIPS can be determined experimentally (Fiorentino et al., 2016), by the coverage method (Fan 
and Quake, 2010) or by the in silico method LoDq (Grendár et al., 2017a). The LoDq method 
exploits the variability of the chromosome representation in euploid samples for determining 
the LoD. It may lead the LoD lower or higher than the customary 4% LoD, implied by the 
coverage method. Moreover, it leads different LoD for different chromosomes. The authors 
(Grendár et al., 2017a) also suggest utilizing both fetal fraction and the chromosome 
representation in the QC of NIPS, and specify the set of pairs of fetal fraction and the 
chromosome representation for which the aneuploidy status of a fetus cannot be determined. 
There are several methods for fetal fraction determination available in the literature. They 
include the chromosome Y-based method ffY (Fan et al., 2008), the seqFF method (Kim et al., 
2015) and the seqFFY method (Grendár et al., 2017a). These methods utilize the data from the 
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WGS, which are used also to obtain the chromosome representation of a sample. Unlike the ffY, 
seqFF, seqFFY methods, which are based on WGS, the class of methods that utilizes a set of 
highly polymorphic Single Nucleotide Polymorphisms (SNPs) - referred to as snpFF, hereafter - 
requires high-coverage targeted sequencing. Thus, snpFF incurs extra costs to NIPS. Several 
variants of snpFF were considered in the literature (Chu et al., 2010a; Jiang et al., 2012; Kang et 
al., 2016; Song et al., 2016; Jiang et al., 2016; Larson et al., 2018). They differ, among other 
things, in complexity of the method for determining the set of informative SNPs.  
The present study aims to explore and quantify the uncertainty of a variant of snpFF, compare it 
with the seqFFY method, and discuss its advantages and disadvantages. We point out that the 
variability of the individual informative SNP-based values of fetal fraction, as quantified by the 
Inter-Quartile Range (IQR) of those values, is rather large and it increases with fetal fraction.  
SnpFF underestimates fetal fraction at the low end of the values (below approximately 7%), 
relative to seqFFY. A potentially useful property of snpFF is its inability to detect fetal fraction 
below approximately 2.5%, which is caused by the small (even zero) number of informative 
SNPs. Unlike the other methods for fetal fraction determination, snpFF thus may suggest 
absence of fetal cfDNA (Takoudes and Hamar, 2015). 
 
2. Material and methods 
2.1 Patient cohort 
Twenty-four women were recruited from the Department of Obstetrics and Gynecology, 
Jessenius Faculty of Medicine, Comenius University, Slovakia. Blood samples (10 mL) were 
collected in BD Vacutainer® tubes (Becton Dickinson, USA)  from pregnant women with male 
fetuses (n=10), female fetuses (n=10) and non-pregnant women (n=4). Pregnant women were at 
different gestation ages (7-19 weeks) and BMI (15-38), to cover wide range values of fetal 
fraction. After the venipuncture, all pregnant participant underwent invasive diagnostic 
procedures (chorionic villus sampling or amniocentesis). Informed consent was obtained from 
all individual participants. 
2.2 Sample processing, DNA extraction and quantification 
Plasma were extracted from 10 ml whole blood samples using a two-step centrifugation process 
(1520 g/10min/4°C and 12052 g/10min/4°C) to remove residual cells. All processed samples 
were stored at −80 °C until the DNA extraction.  DNA was isolated from 2 mL of plasma using 
QIAamp DSP Virus Kit (Qiagen, Germany). The resulting cfDNA was eluted in 80 μL of elution 
solution. The extracted cfDNA was quantified on a Qubit Fluorimeter 3.0 (ThermoFisher 
Scientific) using the Qubit dsDNA HS Assay Kit (ThermoFisher Scientific).  
2.3 DNA size selection 
DNA samples were size-selected using two-step process with AMPure XP beads (Beckman 
Coulter, US). To each sample of cfDNA (80 μL) was added 60 μL beads (ratio 1:0.75), mixed and 
incubated at room temperature for 5 minutes. After incubation were sample placed on 
a magnetic stand until the solution was clear (~7 minutes). The supernatant (140 μL) was 
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transferred to the new tube (to remove large cfDNA fragments). Then was added 259 μL beads 
(ratio 1:1.85), mixed and incubated for 5 minutes at room temperature. After incubation tubes 
were placed on magnetic stand and supernatant was removed and discard (to remove small 
cfDNA fragments). Beads were washed two times by freshly prepared 80% ethanol. After air-
drying procedure to beads was added 65 μL of resuspension buffer (obtained cfDNA fragments 
ranging from 100 to 160bp).  
 
2.4 Targeted sequencing and WGS 
Obtained DNA fragments were used for two different fetal quantification assays. Total volume 
was divided to two part: 60 μL for WGS and 5 μL for high-depth targeted sequencing. Thus, the 
same fragments of cfDNA were used for preparing libraries for both the WGS and targeted 
sequencing. This way, the bias due to different library preparation was minimized.  
 
2.4.1 WGS 
 
The Illumina TruSeq® Nano DNA LT Sample Preparation Kit (Illumina, San Diego, CA) was used for 
library preparation. We followed manufacturer´s protocol from the step 2: Adenylate  
3´ Ends. Final DNA libraries were sequenced on the Illumina HiSeq 1500 in Rapid Run Mode. The 
reads were aligned to human genome hg19 by bowtie2 aligner in BioConductor (Gentleman, 
2004) using the library Rsamtools (Morgan, 2011). Duplicate and poorly aligned reads were 
filtered out using Rsamtools function ScanBamParam with the default setting resulting in a loss 
of ~17% of ~7 million reads. Reads were normalized by all autosomes and binned into 50 kbp 
bins. Fetal fraction was determined by the ffY method (Fan et al., 2008), the seqFF method (Kim 
et al., 2015) and the seqFFY method (Grendár et al., 2017a). 
 
2.4.2 Custom panel - Targeted NGS 
The design of the full-custom AmpliSeq™ Custom DNA Panel for Illumina® was performed by the 
Designstudio (https://designstudio.illumina.com, Illumina, San Diego, CA). The 67 SNPs from 
(Kim et al., 2015) were used. Library preparation was performed according to the 
manufacturer´s protocol. The amplicon size ranged from 125 to 140 bp with an average size of 
135bp. The high-depth sequencing was performed on the Illumina MiSeq instrument.  
Sequencing reads with length 2 x 151bp were mapped to the human reference genome hg19 
using BWA MEM aligner (Li, 2013). Sam files were converted into bam files by BioConductor 
(Gentleman, 2004) library Rsamtools (Morgan, 2011) and nucleotide frequencies were obtained 
by the GenomicAlignments library (Lawrence et al., 2013). All the other computing was done 
using R (R-Development-Core-Team, 2016). SNPs with coverage smaller than 500 were filtered 
out. 
 
3. Theory 
Fetal fraction can be estimated from SNPs at genomic positions that are homozygous in mother 
and heterozygous in fetus (Chu et al., 2010a). Denoting the maternal allele in uppercase and 
letting B be the minor allele, the seven joint maternal-fetal genotypes are:   AAaa, AAab, ABaa, 
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ABab, ABbb, BBab, BBbb. If the respected genotype relative frequencies are nAAaa, nAAab, nABaa, 
nABab, nABbb, nBBab, and nBBbb, then fetal fraction can be estimated as 2nAAab or as 2(0.5 - nABaa), or 
as 2(nABab - 0.5) or as 2(1 - nBBab). Sequencing permits to determine the allelic read counts nα, nβ, 
where α stands for A or a, β stands for B or b. The allelic frequencies are fα = nα/n, fβ = nβ/n, 
where n is the sequencing depth. The latter frequency is the minor allele frequency, denoted 
BAF. Instead of working with fβ it is possible to use fβ’ = min(nα, nβ)/n (Jiang et al., 2012). Not 
every SNP is informative in a particular sample. It is not trivial to tell apart the informative and 
non-informative SNPs (Sparks et al., 2012). The main reason for this difficulty lays in the 
existence of the allelic bias of the sequencing technology (Chu et al., 2010b). There are several 
methods for identifying the informative SNPs. A probabilistic model of the allelic bias was 
proposed by (Jiang et al., 2012). The model involves a mixture of distributions. The model was 
recently extended by (Larson et al., 2018). The authors also proposed a more elaborated 
method of estimating the parameters of the model. Both models can be seen as a probability 
density-based clustering of SNPs. Kim et al. applied the K-means algorithm for the clustering 
(Kim et al., 2015). Clustering assigns each SNP into one of the seven joint genotypes, or the four 
genotypes, if the frequencies are folded around 0.5. 
Another possible method of identifying the informative SNPs, suggested by (Sparks et al., 2012) 
rests on bounds on fβ’. Kang et al. delineate a region in the 2D space of minor and major allele 
frequencies to select the set of informative SNPs (Kang et al., 2016). Regardless of the method 
used for identifying informative SNPs, the relative frequencies of the informative SNPs are used 
to obtain a set of the values of fetal fraction. In some of the variants of snpFF the estimate of 
fetal fraction is obtained as the median (the mean, the weighted average) of the individual 
informative SNPs-based values of fetal fraction, provided the set is sufficiently large. The 
resulting method of fetal fraction determination will be referred to as snpFF. 
Among the other methods of fetal fraction determination the most reliable (Peng and Jiang, 
2017) appears to be the ffY method (Fan et al., 2008; Hudecova et al., 2014) which is based on 
chromosome Y. The method is applicable for the male carrying pregnancies, only. The seqFF 
method (Kim et al., 2015) can determine fetal fraction regardless of the fetal gender, however, 
the method underestimates fetal fraction at the lower and upper ends of the range, relative to 
ffY. The seqFFY method (Grendar et al., 2017a) borrows strength from both ffY and seqFF, and 
corrects the bias of seqFF. For male carrying pregnancies seqFFY is just the ffY method, as it is 
more reliable than seqFF. For female carrying pregnancies ffY cannot be applied, but ffY can be 
calibrated against seqFF, and the calibration curve can be used to predict the ffY value for the 
seqFF value of a female carrying pregnancy. 
 
4. Results 
The values of BAF fβ for a six samples are depicted on Fig. 1. 
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Besides the probability density mixture-based clustering (Benaglia et al., 2009) of fβ’ for the 67 
SNPs in a sample, we have applied also the K-means and K-medoids clustering algorithms 
(Maechler et al., 2018) for identifying the informative SNPs. However, we have achieved the 
best results by the bounds method of (Sparks et al., 2012). The number of informative SNPs 
identified by the method depends on the actual values of the bounds. Sparks et al. suggest using 
1% and 20% bounds (Sparks et al., 2012). A too low value of the lower bound captures some of 
the non-informative SNPs, and leads too small estimates of fetal fraction. A too high value of the 
lower bound may lead a sparse set of informative SNPs and hence unreliable estimates. It is 
necessary to find a balance; in our data the best value of the lower bound was 1.25%. For the 
[1.25, 20]% bounds,  the number of informative SNPs in each sample is depicted on Fig. 2. If the 
set of informative SNPs contained less than 5 SNPs, the snpFF estimate was not provided. There 
are two samples (20, 24) with no informative SNPs and three samples (3, 19, 23) with less than 5 
informative SNPs. Among them, four samples (19, 20, 23, 24) are from non-pregnant females. 
The remaining sample for which snpFF fails to provide estimate of fetal fraction (i.e., sample 3) 
has the seqFFY estimate 1.08%.  Note, that majority of samples have more than 10 informative 
SNPs.  
 
 
Recall that the snpFF estimate of fetal fraction is based on the values of fβ’ (or fβ) for the 
informative SNPs. The snpFF estimate is the median (or the mean) of the individual informative 
values of fetal fraction, denoted snpFFi. The variability of snpFFi is visualized by a boxplot on Fig. 
3 for the 19 samples where snpFF can provide the estimate. The variability is rather large. 
 
The variability is particularly important for the values of fetal fraction close to the Limit of 
Detection (LoD). The LoD of NIPS is typically around 4%. In our data set, there are two samples 
with fetal fraction in [4.5, 5.5]%, with the values of fetal fraction 4.9% and 4.7%. The first sample 
has 10 informative SNPs, the second one has 22 informative SNPs.  The range of the values of ff 
implied by individual informative SNPs is [2.6, 14.6]%, [2.6, 39.0]% for the first, second sample; 
respectively. The lower and upper quartiles are [4.0, 7.4]%, [3.2, 6.8]%; respectively.  
 
 
Crossplot of IQR of snpFFi vs. snpFF, see Fig. 4, indicates that the IQR increases with the increase 
of fetal fraction. The association between IQR of snpFFi and snpFF was quantified by the robust 
linear regression model (Rousseeuw et al., 2015) which had both the intercept (0.017) and slope 
(0.271) statistically significant (p-value 0.047, 0.0005; respectively. T-test of significance of 
predictor).  
 
4.1. Comparison of snpFF and seqFFY methods 
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As it was already mentioned, the same cfDNA fragments were used to prepare library for WGS 
and targeted sequencing. This way, the bias that can be introduced due to differences in library 
preparation was minimized. The WGS was used to determine the ffY and seqFF estimates of 
fetal fraction, which in turn, were used to obtain the seqFFY estimates. These were compared 
with snpFF estimates in the 19 samples where the snpFF method provides estimates. As Fig. 5 
demonstrates, snpFF overestimates fetal fraction for fetal fraction below 7% and overestimates 
it above 7%, relative to seqFFY.  
 
 
5. Discussion 
The snpFF class of methods for fetal fraction determination is based on the high-coverage 
targeted sequencing of highly polymorphic SNPs. The main bottleneck in snpFF is the 
determination of the set of informative SNPs. Several methods for determining the set of 
informative SNPs were proposed, leading different variants of the snpFF method. The set may 
be determined by the hierarchical bayesian density-based clustering, by the K-means or K-
medoids clustering, by the region in the 2D space of minor and major allele frequencies, or by 
the bounds method, among other methods.  
The bounds instance of snpFF, investigated here, estimates fetal fraction by the median of the 
individual informative SNPs-based values of fetal fraction. The individual values, snpFFi, are 
obtained from the relative frequencies of the informative SNPs.  
The variability of the individual informative snpFFi values is rather substantive.  Already the first 
variant of snpFF considered by (Chu et al., 2010a) led the individual informative snpFFi values 
ranging from around 5% to almost 30%, when the true fetal fraction was known to be 10%. 
(Larson et al., 2018) report the values of BAF for 57 SNPs in 120 non-pregnant samples, where 
the BAF is expected to be 50%. The median values of BAF for the SNPs go from around 25% to 
around 75%; see Fig. 1 in (Larson et al., 2018).  
We have quantified the uncertainty of snpFF by the IQR of the individual informative SNPs. The 
IQR increases from some 3% at 4% fetal fraction to 6% at 15% fetal fraction. Thus, the 
uncertainty is non-negligible.  
The snpFF method was not included into the recent comparative study (van Beek et al., 2017) of 
several fetal fraction determination methods. However, the papers on various variants of snpFF 
usually include a comparison of the studied variant of snpFF with some other method of fetal 
fraction determination. Usually, the chromosome Y-based ffY method is used in this role; see 
(Larson et al., 2018; Song et al., 2016). Kim et al. compared the seqFF method with their variant 
of snpFF (Kim et al., 2015). seqFF overestimates fetal fraction relative to snpFF over the entire 
range of values; see Fig. 2C in (Kim et al., 2015). And snpFF underestimates fetal fraction relative 
to ffY; see Fig. 2B in (Kim et al., 2015). Song et al. (2016) have found that their variant of snpFF 
underestimates fetal fraction relative to ffY along the entire range of values. The 
underestimation of snpFF relative to ffY was also reported by (Larson et al., 2018). For their 
variant of snpFF, the underestimation occurs for values of ffY below 10%. This is in a good 
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agreement with our results where snpFF underestimates fetal fraction for seqFFY below 7%. 
Recall, that for the male carrying pregnancies the seqFFY is just the ffY method.  
The snpFF cannot determine fetal fraction below approximately 2.5%, as there tend to be too 
small number of the informative SNPs to provide a reliable estimate. This can be seen as an 
advantage of the snpFF method, since the other methods for fetal fraction determination 
usually lead a positive (or even negative!) values of fetal fraction for non-pregnant samples.  
 
6. Conclusions 
The variant of snpFF method of fetal fraction determination investigated in the present 
communication has similar properties as the other variants of snpFF. In particular, it 
underestimates fetal fraction below ~7%, relative to the chromosome Y-based method ffY, as 
well as relative to the seqFFY method. Variability of the individual informative components 
snpFFi increases with the increase of fetal fraction. The IQR at 4% fetal fraction is around 3% and 
it increases to ~6% at 15% fetal fraction. snpFF cannot detect fetal fraction below 2.5%, because 
the number of informative SNPs becomes too small, even zero. 
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 Fig 1. The BAF fβ for 67 SNPs in a subset of 6 samples. 
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 Fig 2. The number of informative SNPs in the samples. 
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Fig 3. The values of snpFFi for the informative SNPs, overlaid by boxplot to visualize the median 
of snpFFi which is the snpFF estimate. The red triangle is the value of seqFFY estimate of fetal 
fraction. 
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 Fig 4. Crossplot of IQR of snpFFi vs. snpFF, for the 19 samples. The line was fitted by a robust 
linear regression method. IQR, Inter-Quartile Range. 
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Fig 5. Crossplot of the snpFF estimates vs. the seqFFY estimates, for the 19 samples where snpFF 
provides estimates. To facilitate the comparison of the methods, the 45° line (solid line) and the 
OLS fit (dashed line) are added to the plot; see (Grendár et al., 2017b). The OLS fit has the 
intercept 0.022 and the slope 0.678 statistically significant (p-value 0.028, < 0.0001; 
respectively. T-test of significance of predictor) and the Adjusted R2 = 0.611. OLS, Ordinary Least 
Squares. 
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